M&A Deal Summary

Cmbio Acquires Eagle Genomics - e[datascientist] Software Platform

On January 10, 2025, Cmbio acquired software company Eagle Genomics - e[datascientist] Software Platform from Eagle Genomics

Acquisition Highlights
  • This is Cmbio’s 1st transaction in the Software sector.
  • This is Cmbio’s 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2025-01-10
Target Eagle Genomics - e[datascientist] Software Platform
Sector Software
Buyer(s) Cmbio
Sellers(s) Eagle Genomics
Deal Type Divestiture

Target

Eagle Genomics - e[datascientist] Software Platform

London, United Kingdom
Eagle Genomics's e[datascientist] Software Platform is a platform that leverages network science, AI and hypergraph technologies to place data at the heart of Life Science innovation and R&D.

Search 205,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cmbio

Copenhagen, Denmark

Category Company
Sector Software
DESCRIPTION

Cmbio specializes in microbiome science and multi-omics research. Cmbio's team of over 100 experts spans microbiology, bioinformatics, metabolomics, molecular biology, and data science, bringing unparalleled expertise to advance the understanding and impact of the microbiome in global health. Cmbio is based in Copenhagen, Denmark.


DEAL STATS #
Overall 1 of 1
Sector (Software) 1 of 1
Type (Divestiture) 1 of 1
Country (United Kingdom) 1 of 1
Year (2025) 1 of 1

Seller(S) 1

SELLER

Eagle Genomics

London, United Kingdom

Category Company
Sector Software
DESCRIPTION

Eagle Genomics offers enterprise cloud software platform that facilitates data-intensive research in life sciences. The company's platform provides an intuitive approach to curating, integrating, sharing, analyzing, and valuing complex scientific data. Eagle Genomics was founded in 2008 and is based in London, United Kingdom.


DEAL STATS #
Overall 1 of 1
Sector (Software) 1 of 1
Type (Divestiture) 1 of 1
Country (United Kingdom) 1 of 1
Year (2025) 1 of 1